Measurements were made of heart rate, aortic blood pressure, systolic ejection period/beat, myocardial blood flow, and myocardial oxygen consumption in nine normal young men during three bouts of upright bicycle exercise: 1) at the workload which produced a heart rate of 120 beats/minute, 2) at the higher workload necessary to produce a heart rate of 120 beats/minute after administration of intravenous propranolol 0.25 mg/kg, and 3) with infusion of propranolol, at the same workload as the first exercise bout. Comparing exercises 1 and 2, we found a much higher workload was required to produce the same heart rate after propranolol. The blood pressure, heart rate-blood pressure product, and myocardial oxygen consumption were the same despite the much greater level of exertion. Comparing exercises 1 and 3, the heart rate, blood pressure, heart rate-blood pressure product, and myocardial oxygen consumption were all significaritly lower during exercise 3 after propranolol despite the fact that the same degree of exercise was being done. As in previous studies, the heart rate-blood pressure product was an excellent correlate of myocardial oxygen consumption despite the change in contractility induced by propranolol. The systolic ejection period was prolonged significantly altering the tensiontime index (TTI), which became an inadequate index of myocardial oxygen consumption. It is concluded that the heart rate-blood pressure product is a good index of myocardial metabolic needs during exercise and the relationship is undistorted by marked changes in contractility, but the tension-time index is a poor correlate. This data emphasizes the fact that the relative metabolic loads for the whole body and for the heart are determined separately and may not change in parallel with a given intervention.
Systolic ejection period Myocardial blood flow pectoris during upright bicycle exercise have been previously reported.' It was concluded that the products of heart rate and aortic blood pressure (HR X BP) correlated best with MBF and MVO2, but the heart rate alone correlated almost as well. The tensiontime index, peak systolic aortic pressure, external workload, and total body oxygen consumption were poorer correlates. During the heavy2 dynamic work utilized in that study, of the major determinants of MV02, the major change was in heart rate and the blood pressure increased moderately. However, there was no way to evaluate the possible contribution of changes in contractility, another of the major determinants of MV'02. 3 The present investigation was designed to evaluate the ability of easily measured hemodynamic variables to predict the MBF and MVO2 in the presence of marked alterations in contractility induced by beta-adrenergic blockade with propranolol.
Methods Subjects Data were obtained in nine normal male volunteers whose ages ranged from 22 to 25 years. All were university students and none were engaged in athletic training or heavy physical labor. All were of normal body build, and they were relatively homogeneous as a group. Review of each individual's health record and examination of the heart and the lungs eliminated subjects with any cardiac or pulmonary disease.
The study protocol was approved by the University of Minnesota Clinical Research Committee on the Use of Human Volunteers in Research on March 17, 1971. The over-all purpose and the design of the study were explained to the subjects as a group, and the catheterization equipment and procedure were shown to each subject individually before informed consent was obtained. Subjects were free to drop out of the study at any point.
Experimental Protocol
Three stages of upright bicycle exercise were used as follows:
Exercise #1: At the workload necessary to produce a heart rate of 120 beats/min. Exercise #2: At the workload necessary to produce the same heart rate as in Ex. #1 (120 beats/minute) following intravenous infusion of propranolol 0.25 mg/kg. Exercise #3: At the same workload as in Ex. #1 after intravenous infusion of additional propranolol, one-half the initial dose (0.125 mg/kg). A 30 min recovery period was allowed between each exercise. Propranolol was infused over a period of five minutes and an additional five minutes were allowed before Ex. #2 and Ex. #3 began. By one hour after giving intravenous propranolol there is a significant recovery of the depression of exercising heart rate,4 despite the fact that its half-life in the plasma is of the order of two and one-half hours.5 6 Therefore, the additional propranolol was given before Ex. #3.
Exercise #1 and #2 compare the effect of exercise at a different workload but at the same heart rate before and after propranolol; Ex. #1 and #3 compare exercise at the same workload before and after infusion of propranolol, and data from Ex. #2 and #3 can be compared to data obtained during exercise without propranolol.
The workloads necessary to produce a heart rate of 120 beats/minute before and after infusion of propranolol were predetermined during two preliminary studies in each individual. The total body oxygen consumption (V-OJ) at these workloads was measured, and the 0T2 during the subsequent MBF study was estimated from this data as previously described.' Maximal total body VO. was detennined on all subjects on another day utilizing a motor-driven treadrmill.7
Procedure
On the day of the MBF study, subjects reported to the cardiac catheterization laboratory in a fasting state. The room temperature was maintained at 210 C. With the subject in the supine position, a siliconized 7 F Goodale-Lubin catheter 125 cm in length was percutaneously introduced into the median basilic vein and the tip of the catheter was positioned in the coronary sinus 2 cm from the left cardiac border under fluoroscopic visualization. The position of the catheter tip was verified by oxygen saturation and by injecting contrast material. A 75 cm 5 F Teflon catheter was introduced into the brachial artery by the Seldinger technique, and the catheter tip was positioned in the ascending aorta 5 cm above the aortic valve. A six foot PA chest roentgenogram was taken in the upright sitting position at rest before exercise 1 and 2 in three subjects to be sure propranolol did not induce gross changes in heart size. The area of the cardiac silhouette was determined by planimetry and was unchanged, but the films were not exposed at any one particular time in the cardiac cycle. The subject walked from the fluoroscopy table to the bicycle in the same room and mounted it. Blood was again drawn through the venous catheter to determine the oxygen saturation to be sure that the catheter tip was still in the coronary sinus. The zero reference point for pressure measurement in the upright position was the fourth intercostal space at the left sternal border. Central aortic pressure, mean coronary sinus pressure, and the ECG were recorded simultaneously over at least two respiratory cycles at paper speeds of 25, 100, and 200 mm/second.
Coronary sinus pressure was used to monitor the respiratory cycles. Then Ex. #1 was begun at the predetermined workload. The ECG was monitored throughout the study and the heart rate was counted every minute. Small (20% or less) changes in workload were made in a few instances to maintain the heart rate at the preset level of 120 beats/minute. When a steady state had been achieved, the blood pressures and the ECG were again recorded. Using 15% nitrous oxide, MBF and MVO9 were measured by the nitrous oxide (N20) saturation method, modified with regard to timing of sampling and the integration of the arteriovenous nitrous oxide difference.8 The sampling rate was slightly different from that previously described,8 being 8 ml/40 sec in each syringe for the first five paired arterial and coronary sinus specimens and 8 ml/80 sec for the last two sets to check final equilibration. Ten seconds were allowed between each set of paired samples for changing the syringes and clearing the catheter system of blood from the previous sampling period. Additional blood samples were obtained for determination of blood gases and hemoglobin concentration. Blood pressures and ECG were recorded immediately before and following the blood sampling, and averaged values were used for calculations. After reaching a constant heart rate, approximately 15 min-utes were utilized in recording hemodynamic measurements and collecting blood samples. After exercise, fluoroscopy was used with the subject in the supine position to ascertain that the catheter position in the coronary sinus was unchanged. MBF, MVO9, and hemodynamic measurements during Ex. #2 and #3 were carried out in the same manner as in Ex. #1. Aortic ratio of change in pressure to change in time (dp/dt) correlates well with left ventricular dp/dt,9 and this was recorded during exercise in two subjects. Blood loss was approximately 160 ml for each MBF measurement and this volume, plus an additional amount for perspiration losses, was replaced by saline during the procedure.
An Electronics for Medicine, Inc., multichannel photographic recorder was used for recording pressures and the ECG. Statham P23Gb pressure transducers were used. The damped natural frequency of the pressure recording system varied from 28 to 167 cps. Blood pH, pO, and pCO2 were determined with an Instrumentation Laboratory model 113 blood gas analyzer and converted to percent saturation with oxygen,10 and the oxygen content was derived from this data and the hemoglobin measured by the cyanmethemoblogin method." In our laboratory oxygen saturation determined from blood gases is slightly lower than by the Van Slyke method (mean difference -0.1 ± 3.0% oxygen saturation; P > 0.50), and oxygen capacity calculated from the hemoglobin is slightly higher than by the Van Slyke method (mean difference 0.11 ± 0.25 gm% hemoglobin, 0.10 > P > 0.05).
CalcuIations
For comparability with previous data" 12 a value of 1.0 was used for the coefficient of partition of N20 between left ventricular myocardiurm and blood in calculating MBF, despite the fact that a recent study indicates 0.934 is the value for normal man.13 MVO2 was calculated as the product of MBF and the difference in oxygen content between the aorta and the coronary sinus (A-V 02 difference) and expressed as ml of oxygen per 100 g of left ventricular myocardium per minute. Coronary vascular resistance was calculated by dividing mean aortic pressure by MBF and expressed as mm Hg/mI/ 100 g left ventricle/min. Tension-time index (TTI) per beat was measured by integrating with a polar planimeter (Dietzgen D-1806) the systolic portion of the aortic pressure tracing, which was recorded at a paper speed of 200 mm/sec. The systolic ejection period/beat (SEP/beat) was derived from this calculation. Complexes over two or three complete respiratory cycles were measured and averaged. Standard statistical methods were used.14
Results
Values for the individual measurements in each subject with means and standard deviations for the group are given in table 1. The mean estimated total body Vo2 at the two bicycle ergometer workloads used is 35% and 57% of the mean measured maximal total body V02 measured during Circulation, Volume XLVIII, December 1973 treadmill exercise, and is comparable to previously reported values at comparable workloads.' There was no significant difference in the oxygen consumption at the same workload before and after propranolol as determined during the preliminary studies (difference between means 0.02 liters/min, 0.9 > P > 0.8).
The arteriocoronary sinus oxygen (coronary A-V02) difference during exercise before propranolol is wider than expected from our previous data,1 and hence the mean value for MVO2 during the control period Ex. #1 (22.1 ml/100 gm LV/min) is somewhat higher at the mean heart rate of 120 beats/minute than predicted (19.6 ml/100 gm LV/min), but all individual values were within the previously established 95% confidence limits. Since the previous report we have changed methods for oxygen analysis but there is good agreement between these methods in our laboratory (see Methods), and the reliability of our MBF determination has also been established.8 There is no apparent explanation for this difference in coronary A -V 02 difference.
Comparison of exercises 1 and 2 (table 1, fig. 1 ) shows that a significantly higher external workload (112 vs 63 W) and total body oxygen consumption were required to produce the same heart rate after propranolol administration. The aortic blood pressure and HR x BP were the same despite the higher workload; although the myocardial oxygen consumption fell slightly, the change was not significant. However, this similar MV02 was achieved by means of a significantly higher A -V 02 difference and significantly lower MBF after propranolol, although coronary vascular resistance was not significantly higher. The average maximum aortic dp/dt during exercise in the two subjects in whom it was measured fell from 1606 to 1216 mm Hg/sec after propranolol. With the prolongation of ejection from 0.223 to 0.247 sec/beat the tensiontime index (TTI) per min increased, although the change was not statistically significant (P = 0.08). Nevertheless it should be noted that the TTI increased while the MVO2 fell.
Comparing exercises 1 and 3 (table 1, figure 1 ), that is, work at the same external load before and after propranolol, all measured variables except arteriocoronary sinus 02 difference were changed significantly. Heart rate, aortic blood pressure, HR x BP, TTI MBF, MV02 were lower after propranolol; SEP and coronary vascular resistance were higher. The maximum aortic dp/dt during exercise was decreased to 850 mm Hg/sec. The significant increase in SEP/beat, from 0.223 to 0.258 sec appears to be a further manifestation of the decrease in contractility. SEP/beat is prolonged because propranolol at the same level of exercise causes little change in stroke volume'5' 16 and a decrease in systolic ejection rate.'6 It is important to note that the same external workload can be accomplished at a MVO2 which is 35% lower after propranolol. The data from exercise 1 of this study (control, no propranolol, average heart rate 120 beats/minute) was combined with the data from three other levels of upright dynamic bicycle exercise previously reported' (average heart rates 104, 145, and 171 beats/minute) to recalculate regression lines and the correlation coefficients for the relationships between heart rate, HR x BP, and TTI with MBF and MVO2. These lines are plotted in figures 2-4 along with the 95% confidence zone for individual points (dashed lines) and the 95% confidence zone for the slope of the regression line (shaded area). Superimposed on these relationships are plotted the points and the corresponding regression lines for the two levels of exercise carried out after the administration of propranolol. After beta-adrenergic blockade all measurements of MBF and MVO2 fall well within the area to be expected with the heart rate or HR x BP, but four and one points, respectively, fall outside the established 95% confidence zones for the relationship of TTI with MBF and MVO2. The slopes for the regression lines fall within the 95% confidence zones after propranolol for both heart rate and HR x BP with MVO2 but not MBF. In the case of the TTI the slopes fall far outside the expected range for both variables.
The correlation coefficients are given in table 2. Again calculations have been made combining data from the previously reported study with the current study. Again the HR x BP is found to be the best correlate of both MBF and MVO2, the heart rate alone is nearly as good, and the TTI is the poorest, EFFECT OF PROPRANOLOL HEART RATE, beats/min Figure 2 Relationship of myocardial blood flow (above) and consumption (below) and heart rate. The values on the abscissa cover the entire range over which we have made measurements. The regression line for all our data on upright dynamic exercise without propranolol is given by the solid line along with 95% confidence zones for the individual points (dashed line) and 95% confidence zones for the slope of the regression line (shaded area). The plotted points are for the two levels of exercise carried out after administration of propranolol, the solid dots indicating the heavy exercise load and the open dots indicating the lighter load. The regression line for these points is dotted. but the differences between the correlation coefficients, although larger, are still not significantly different.
Since beta-adrenergic blockade did not seem to distort the relationships between heart rate and HR x BP with MBF and MVO2 (figures 2, 3) all data from both studies without and with propranolol were utilized to calculate correlation coefficients (table 2). The HR x BP product and the heart rate are still very good correlates of MBF and MVO2 with these varying conditions, but the TTI is now significantly worse than either HR X BP or heart rate.
Some authors have used the triple product, a variant of the TTI, as an index of myocardial oxygen needs.'7 The triple product is the product of the heart rate, peak systolic aortic pressure, and the systolic ejection period/beat; the only difference between this calculation and TTI is that the latter uses the mean systolic aortic pressure. Using all our data for upright dynamic exercise without propranolol, we calculated coefficients of 0.72 and 0.68 for the correlation of the triple product with MBF and MVO2 respectively. These compare with the Circulation, Volzme XLVIII, December 1973 correlation coefficients of 0.73 and 0.68 for the TTI indicating that the triple product shares the same deficiencies as the TTI in predicting MVO2.
Discussion
Beta-adrenergic blockade is known to have a significant effect on the circulatory responses to exercise in man. At any given level of submaximal exercise it produces a fall in heart rate and cardiac output. The lowered cardiac output is compensated for by an increase in systemic A -V O2 difference so that there is no alteration in Vo2. However this compensation is not adequate during maximal exercise and thus the capacity for strenuous exertion is reduced.15 It has been demonstrated that in the sitting position beta blockade increases the systolic and diastolic transverse diameter of the heart during both exercise and rest. '8 A number of studies of MFB and MVO2 after beta adrenergic blockade have been done in a variety of animal preparations including a dog heart-lung bypass,19 anesthetized dogs,20-24 and unanesthetized dogs,25' 26 *P is the probability that the differetnces between the correlation coefficients for the TTI and HR, and for the TTI aind HR X BP respectively are inisignificant, i.e., the lower the P value the more significanlt the differeince. Abbreviations: HR = heart rate; TTI = tension-time index; BP = blood pressure; MBF = mvocardial blood flow; MVO2 = myocardial oxygen consumption. blood pressure were similar after beta adrenergic blockade, MBF and MVO2 also remained unchanged, but if the heart rate and blood pressure were altered, the MBF and MVO2 would vary in the same direction as the hemodynamic variables.
Similar results are reported from studies performed in man. At rest27-30 any decrease in MBF is usually associated with a similar decrease in indices of left ventricular effort, but a disproportionately high increase in coronary vascular resistance was found in one study.28 Studies during exercise are small in number,29 30 and are limited to mild (increase in total body Vo2 of 2.25 times29 and 400 kpm/min or 67 W30) supine leg exercise. Again the decreases in MBF and MVO2 as compared to exercise before blockade are associated wth lower values for hemodynamic measurements. One study30 also found that the oxygen content and the quotient of pyruvate/lactate in coronary sinus blood were lower as well, a relationship suggesting a decreased tissue oxygen supply, possibly due to a reduced metabolic vasodilatation because of unopposed adrenergic alpha receptor stimulation.30 1 One can summarize these diverse studies by stating that at rest beta blockade produces no change or a decrease in MBF in association with decreases in heart rate, cardiac output, and blood pressure. During mild exercise the increase in MBF is less than in similar exercise before blockade, again in parallel with systemic hemodynamic changes. There is the suggestion that changes in MBF are out of proportion to changes in metabolic demands after beta blockade with an increase in coronary vascular resistance and increased extraction of oxygen from the blood.
Our results are in concert with the data summarized above. During exercise after propranolol the MVO2 at any given workload is significantly lower than before the drug, but in parallel with the lower heart rate and blood pressure. However, this MVO2 is achieved by a proportionately lower MBF and higher oxygen extraction, i.e., a lower coronary sinus PO2 and derived oxygen content, as noted by others.30 It is possible the oxygen extraction was even greater after propranolol than the values given in table 1. Propranolol has been reported to produce a redistribution of 2,3-diphosphoglycerate in the red cell so that the affinity of hemoglobin for oxygen is decreased allowing more oxygen to be delivered to the myocardium at a given PO2.32 This work requires further confirmation, but since we did not determine oxygen content directly but rather derived the value from the PO2 and a normal dissociation curve, the absolute values of MVO2 after propranolol reported could be low. However, for the portion of the hemoglobin-oxygen dissociation curve on which our coronary sinus P02 values fall (20 mm Hg), the rightward shift of the curve is small, even with very high propranolol concentra-Circulation, Volume XLVIII, December 1973 llS0 PROPRANOLOL AND EXERCISE tions, and would produce a difference in oxygen saturation of only about 2%. 33 Furthermore, this would not affect the slope of the regression lines calculated from the data obtained after propranolol administration (dotted lines in figures 2-4), and we believe our conclusions regarding the correlations between various hemodynamic indices and MVO.. are not affected by this methodologic issue.
We previously concluded the HR x BP, or even the heart rate alone, is a good index of the heart's metabolic demands during normal exercise, and it appears that this is still valid, even when contractility, one of the major detenninants of MVO2,3 is markedly altered. The deficiencies of the measure TTI and its variant, the triple product, as indices of the heart's oxygen needs become more apparent when the systolic ejection period is altered by propranolol. This also supports the previous sug-gestion34 that the maintenance of tension is not an important determinant of MV02.
Thus only two variables provide a satisfactory assessment of the load on the heart. This does not imply that heart rate and blood pressure are the only major determinants of MVO2, but suggests that other known significant factors3 must vary in parallel with these two variables or cancel out in such a way that HR x BP provides an excellent index of myocardial metabolic needs. This is fortunate since these two are simple to determine relative to such quantities as ventricular yolume and contractility, although measurement of central aortic pressure as in these studies is obviously an invasive technique. It is likely that cuff blood pressure determinations would be interchangeable but their applicability requires further delineation.
These data emphasize the previously noted separation of the metabolic load for the body as a whole induced by a given intervention from the concomitant metabolic demands of the heart,' explaining the usefulness of propranolol as therapy for angina pectoris. The majority of published reports indicate that propranolol improves the exercise tolerance and ischemic ECG changes during exercise of patients with angina pectoris when adequate doses are given.'7' 35 36 Our work with propranolol demonstrates that this agent causes marked decreases in the metabolic load on the heart for any given metabolic load on the entire body, or conversely, that at any given cardiac load -for example, the point at which angina occursthe attainable total body or external workload is much higher. At the same time it is recognized that Circulation, Volume XLVIII, December 1973 the HR x BP value at which angina occurs is slightly lower after either infusion of propranolol or practolol, even though the exercise capacity is significantly increased.37 3 The dose of intravenous propranolol used in this study was relatively large, but the pharmacologic effect, and hence the effects on hemodynamics and MV02, may be comparable to that obtained in patients being treated with chronic oral propranolol therapy for angina. The optimum dose for angina therapy,36 the plasma levels required for optimum effect,39' 40, 41 the plasma levels attained with various oral administration regimens,4' 39, 40, 41 and the plasma levels associated with intravenous administration of various doses5 6 all suggest this comparability.
